Literature DB >> 26884422

Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes.

David Ahn1, Jeremy Pettus2, Steven Edelman2.   

Abstract

The original continuous glucose monitors (CGMs) were limited to 3-day, blinded observation periods where glucose data was hidden from patients and later retrospectively analyzed by a provider to help guide the management of diabetes. Unblinded CGM, released several years later, allows patients to view their glucose data in real-time amidst their daily routines, enabling them to better understand how variables such as activity, nutrition, and medications affect glucose levels. Research studies consistently demonstrate improved glycemic control and reduced hypoglycemia in children and adults with type 1 and type 2 diabetes while using unblinded CGM.(1-4) As such, we believe that all CGM usage in clinical practice should be in real-time, unblinded mode for short-term and long-term wear periods.
© 2016 Diabetes Technology Society.

Entities:  

Keywords:  CGM; continuous glucose monitor; glucose monitoring; glucose sensor

Mesh:

Substances:

Year:  2016        PMID: 26884422      PMCID: PMC5038541          DOI: 10.1177/1932296816632241

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  23 in total

1.  Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.

Authors:  T Skrivarhaug; H-J Bangstad; L C Stene; L Sandvik; K F Hanssen; G Joner
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

2.  Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.

Authors:  Thomas C Blevins; Bruce W Bode; Satish K Garg; George Grunberger; Irl B Hirsch; Lois Jovanovič; Elizabeth Nardacci; Eric A Orzeck; Victor L Roberts; William V Tamborlane; Caitlin Rothermel
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

3.  (6) Glycemic targets.

Authors: 
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

4.  Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.

Authors:  Robert Tanenberg; Bruce Bode; Wendy Lane; Claresa Levetan; Jorge Mestman; Anne Peters Harmel; Janet Tobian; Todd Gross; John Mastrototaro
Journal:  Mayo Clin Proc       Date:  2004-12       Impact factor: 7.616

5.  Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.

Authors:  Gary M Pepper; Jamie Steinsapir; Kathryn Reynolds
Journal:  Diabetes Technol Ther       Date:  2012-06-12       Impact factor: 6.118

6.  Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults.

Authors:  Richard G Feltbower; H Jonathan Bodansky; Christopher C Patterson; Roger C Parslow; Carolyn R Stephenson; Catherine Reynolds; Patricia A McKinney
Journal:  Diabetes Care       Date:  2008-02-19       Impact factor: 19.112

7.  Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial.

Authors:  Nancy A Allen; James A Fain; Barry Braun; Stuart R Chipkin
Journal:  Diabetes Res Clin Pract       Date:  2008-03-04       Impact factor: 5.602

8.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

9.  Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

Authors:  Tim Heise; Leszek Nosek; Birgitte Biilmann Rønn; Lars Endahl; Lutz Heinemann; Christoph Kapitza; Eberhard Draeger
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

10.  Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.

Authors:  William H Polonsky; Lawrence Fisher; Charles H Schikman; Deborah A Hinnen; Christopher G Parkin; Zhihong Jelsovsky; Bettina Petersen; Matthias Schweitzer; Robin S Wagner
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

View more
  13 in total

Review 1.  Closing the Loop.

Authors:  Revital Nimri; Nathan Murray; Alexander Ochs; Jordan E Pinsker; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2017-02       Impact factor: 6.118

2.  Sleep, self-management, neurocognitive function, and glycemia in emerging adults with Type 1 diabetes mellitus: A research protocol.

Authors:  Stephanie Griggs; Nancy S Redeker; Sybil L Crawford; Margaret Grey
Journal:  Res Nurs Health       Date:  2020-07-08       Impact factor: 2.228

3.  Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.

Authors:  David L Levitt; Elias K Spanakis; Kathleen A Ryan; Kristi D Silver
Journal:  Diabetes Technol Ther       Date:  2018-01-02       Impact factor: 6.118

Review 4.  How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?

Authors:  Ramzi A Ajjan
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 5.  Diabetes: the role of continuous glucose monitoring.

Authors:  Julianna Rivich Kluemper; Alexandria Smith; Brooke Wobeter
Journal:  Drugs Context       Date:  2022-06-14

Review 6.  Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation.

Authors:  Grazia Aleppo; Kimberly Webb
Journal:  J Diabetes Sci Technol       Date:  2018-11-19

Review 7.  Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes.

Authors:  Jeremy Pettus; Steven V Edelman
Journal:  J Diabetes Sci Technol       Date:  2016-08-20

8.  Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.

Authors:  Khalid Sheikh; Sara K Bartz; Sarah K Lyons; Daniel J DeSalvo
Journal:  J Diabetes Res       Date:  2018-07-29       Impact factor: 4.011

9.  Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.

Authors:  Ramzi A Ajjan; Neil Jackson; Scott A Thomson
Journal:  Diab Vasc Dis Res       Date:  2019-07       Impact factor: 3.291

10.  Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A  Practical Guide.

Authors:  Gary Deed; Roy Rasalam; Chee Khoo; Tom Dover; Nick Forgione
Journal:  Diabetes Ther       Date:  2019-10-21       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.